Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells

• Published in: Biochimica et biophysica acta Vol. 1104; no. 1; pp. 111 - 116
• Main Authors: Ferrer-Montiel, A V, Gonzalez-Ros, J M, Ferragut, J A
• Format: Journal Article
• Language: English
• Published: Netherlands 17.02.1992
• Subjects: Animals; Cell Membrane - metabolism; Daunorubicin - metabolism; Daunorubicin - pharmacology; Drug Resistance; Energy Transfer; Fluorescence; Leukemia P388 - metabolism; Leukemia, Experimental; Mice; Tumor Cells, Cultured
• ISSN: 0006-3002
• DOI: 10.1016/0005-2736(92)90138-C

When the anthracycline daunomycin (DNM) is incorporated into isolated plasma membranes from P388 murine leukemia cells, the drug partitions between 'deep' and 'surface' membrane domains. Such domains have been characterized on the basis of: (1) fluorescence resonance energy transfer between 1,6-diphenylhexa-1,3,5-triene or 1-[4-(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene as energy donors, which are well known in their positioning within the membrane, and daunomycin as the energy acceptor, and (2) quenching of the fluorescence of the membrane-associated drug by the water-soluble quencher iodide. The distribution of DNM between the two plasma membrane domains is different depending on the cellular phenotype. Thus, in membranes from drug-sensitive cells, DNM is preferentially confined to 'surface' domains, while in membranes from drug-resistant cells, the drug distributes more homogeneously between 'surface' and 'deep' domains. Experiments using artificial lipid vesicles suggest that differences in the relative levels of certain lipids in the plasma membranes from drug-sensitive and drug-resistant cells, namely phosphatidylserine and cholesterol, are partly responsible for the observed differences in the distribution of DNM. Since drug-membrane interactions are important in anthracycline cytotoxicity, it is possible that our observations on a different membrane distribution of daunomycin, may be related to the different sensitivity to the drug exhibited by these cells.